Sisältö
Maksutavat
Toimitus Vaihtoehto






Ostoskori
Ihmiset jotka ostivat tämän, ostivat myös:
Grisactin is an antifungal medication which is used to treat fungal infections of the skin, hair, and nails.
$0.57
Osta nyt
Nizoral is an antifungal antibiotic which is used to treat candidiasis, blastomycosis, coccidioidomycosis, histoplasmosis, chromoblastomycosis, or paracoccidioidomycosis.
$1.73
Osta nyt
Sporanox is an azole antifungal medicine used used to treat blastomycosis, histoplasmosis and aspergillosis.
$4.38
Osta nyt
Phenergan is treating different types of allergy symptoms, including itching, runny nose, sneezing, itchy or watery eyes, hives, and itchy skin rashes.
$0.41
Osta nyt
Grifulvin V is an antifungal medication which used to treat fungal infections of the skin, scalp, and nails.
$0.82
Osta nyt
Diflucan on sieniä vastaan suunnattu antibiootti, jota käytetään eri elinten hoitona hiivasienitulehdusta vastaan, sukupuolielinten alue mukaan lukien.
$0.88
Osta nyt
Suosittelut
Giancarlo Carmagnini, Firenze, Italy
KIITOS nopeasta vastauksesta. Odotan jo kuulevani teistä jatkossa!! Vastaanotin yllämainitun tilaukseni nyt lauantaiaamuna. Kaikki on ok!!! Kiitoksia ja ollaan yhteydessä. Toivotan teille upeaa päivää!!! Vanessa, Hermitage
Olen saanut tilauksen ja aion tilata toisenkin pian.
Sosiaaliset kirjanmerkit
Uutiset
'It gave me my voice back': How group singing is helping new mums with postnatal depression
New research suggests singing can be clinically effective at treating the symptoms and cost effective for the NHS. Questions over mysterious death in mental health hospital
An inquest into Maria Morris's death found it was accidental, but her family still have questions over what happened the night she died. Health minister defends timeline on dealing with winter pressures
Mike Nesbitt said a plan has been developed, but not yet been finalised, and will be published on Thursday. NHS stripped ex-footballer of dignity, say family
Failings in Colin Flatt's care in the final months of his life are laid bare in a new report.